| abstract |
It is intended to provide drugs which contain as the active ingredient at least one member selected from among riboflavin, riboflavin derivatives and pharmacologically acceptable salts thereof and have an effect of inhibiting a cytokine such as IL-1β, IL-6, IL-10, INF-Ϝ, TNF-α, GM-CSF, IL-8 or MCP-1; and preventives or remedies for inflammatory diseases accompanied by hypercytokinemia which have an excellent cytokine inhibitory effect. |